Evidence map›Paper›PMID 28505189›Full record

ArticlePloS one2017

Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.

Benjamin Rengstl, Sooji Kim, Claudia Döring, Christian Weiser, Julia Bein, Katrin Bankov, Marco Herling, Sebastian Newrzela, Martin-Leo Hansmann, Sylvia Hartmann

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Benjamin RengstlDr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
Sooji KimDr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
Claudia DöringDr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
Christian WeiserDr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
Julia BeinDr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
Katrin BankovDr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
Marco HerlingLaboratory of Lymphocyte Signaling and Oncoproteome, Department of Internal Medicine I, University of Cologne, Cologne, Germany.
Sebastian NewrzelaDr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
Martin-Leo HansmannDr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
Sylvia HartmannDr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
Goethe University Frankfurt · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hallmark of classical Hodgkin lymphoma (cHL) is the presence of giant, mostly multinucleated Hodgkin-Reed-Sternberg (HRS) cells. Whereas it has recently been shown that giant HRS cells evolve from small Hodgkin cells by incomplete cytokinesis and re-fusion of tethered sister cells, it remains unsolved why this phenomenon particularly takes place in this lymphoma and what the differences between these cell types of variable sizes are. The aim of the present study was to characterize microdissected small and giant HRS cells by gene expression profiling and to assess differences of clonal growth behavior as well as susceptibility toward cytotoxic intervention between these different cell types to provide more insight into their distinct cellular potential. Applying stringent filter criteria, only two differentially expressed genes between small and giant HRS cells, SHFM1 and LDHB, were identified. With looser filter criteria, 13 genes were identified to be differentially overexpressed in small compared to giant HRS cells. These were mainly related to energy metabolism and protein synthesis, further suggesting that small Hodgkin cells resemble the proliferative compartment of cHL. SHFM1, which is known to be involved in the generation of giant cells, was downregulated in giant RS cells at the RNA level. However, reduced mRNA levels of SHFM1, LDHB and HSPA8 did not translate into decreased protein levels in giant HRS cells. In cell culture experiments it was observed that the fraction of small and big HRS cells was adjusted to the basic level several days after enrichment of these populations via cell sorting, indicating that small and big HRS cells can reconstitute the full spectrum of cells usually observed in the culture. However, assessment of clonal growth of HRS cells indicated a significantly reduced potential of big HRS cells to form single cell colonies. Taken together, our findings pinpoint to strong similarities but also some differences between small and big HRS cells.

Indexed as

Gene Expression ProfilingTranscriptomeAntineoplastic AgentsBiomarkersBrentuximab VedotinCell Line, TumorCell SizeCluster AnalysisGene Expression Regulation, NeoplasticHodgkin DiseaseHumansImmunoconjugatesImmunohistochemistryImmunophenotypingReed-Sternberg CellsAntineoplastic AgentsBiomarkersBrentuximab VedotinImmunoconjugates

Identifiers

PMID28505189
PMCPMC5432067
OpenAlexW2615690326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.